Lap Chole & End-Stage Renal Disease (ESRD): Metabolic Logic
General specialty scenario focusing on electrolyte optimization, diabetic autonomic neuropathy, and chronic organ failure.
"A 46 y.o. man is scheduled for a laparoscopic cholecystectomy. PMH: Type I DM, retinopathy, neuropathy, and End-Stage Renal Disease (ESRD) on hemodialysis. Last HD was yesterday. K+ 5.3 mEq/L. Mallampati 3."
Management of hyperkalemia, diabetic autonomic neuropathy (delayed gastric emptying), and cardiovascular risk in End-Stage Renal Disease (ESRD).
A 'staple' board scenario that pivots from simple general surgery into multi-system metabolic crises (Advanced Cardiovascular Life Support (ACLS), hyperkalemia, difficult airway).
How a Board-Certified Consultant answers this scenario.
This End-Stage Renal Disease (ESRD) patient needs careful management of his volume status and electrolytes, especially potassium (K+). With a baseline K+ of 5.3, I will avoid succinylcholine and instead use rocuronium for any required muscle relaxation, which I will reverse with sugammadex to ensure complete recovery without reliance on renal excretion.
I will request the surgeon to use a low-pressure pneumoperitoneum to minimize the impact on venous return and renal blood flow, although his native kidneys are already non-functional. I will avoid any nephrotoxic agents and monitor for ECG changes indicative of hyperkalemia during the procedure. I'll maintain a 'fluid-restrictive' strategy to prevent pulmonary edema, as he cannot excrete excess volume. Post-operatively, I will coordinate with the nephrology team for scheduled dialysis, targeting within 24 hours of the surgery while ensuring adequate pain control without overly relying on renally-cleared opioids.